These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28705733)

  • 1. Platelet oxidative stress as a novel target of cardiovascular risk in frail older people.
    Fuentes F; Palomo I; Fuentes E
    Vascul Pharmacol; 2017 Aug; 93-95():14-19. PubMed ID: 28705733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet oxidative stress and thrombosis.
    Violi F; Pignatelli P
    Thromb Res; 2012 Mar; 129(3):378-81. PubMed ID: 22209450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis.
    Fuentes E; Gibbins JM; Holbrook LM; Palomo I
    Trends Cardiovasc Med; 2018 Oct; 28(7):429-434. PubMed ID: 29661712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
    Khodadi E
    Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age associated non-linear regulation of redox homeostasis in the anucleate platelet: Implications for CVD risk patients.
    Jain K; Tyagi T; Patell K; Xie Y; Kadado AJ; Lee SH; Yarovinsky T; Du J; Hwang J; Martin KA; Testani J; Ionescu CN; Hwa J
    EBioMedicine; 2019 Jun; 44():28-40. PubMed ID: 31130473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients.
    El Haouari M
    Curr Med Chem; 2019; 26(22):4145-4165. PubMed ID: 28982316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
    Sepúlveda C; Palomo I; Fuentes E
    Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Platelet Activation and Oxidative Stress in the Evolution of Myocardial Infarction.
    Fuentes E; Moore-Carrasco R; de Andrade Paes AM; Trostchansky A
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):509-520. PubMed ID: 31280622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet dysfunction in central obesity.
    Anfossi G; Russo I; Trovati M
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):440-9. PubMed ID: 19346117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet function during frailty.
    Hernández B; Fuentes E; Palomo I; Alarcón M
    Exp Hematol; 2019 Sep; 77():12-25.e2. PubMed ID: 31476327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of oxidative stress on platelet hyperreactivity during aging.
    Fuentes E; Palomo I
    Life Sci; 2016 Mar; 148():17-23. PubMed ID: 26872977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Signaling Pathways and New Inhibitors.
    Grover SP; Bergmeier W; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e28-e35. PubMed ID: 29563117
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxidative Stress, Frailty and Cardiovascular Diseases: Current Evidence.
    Uchmanowicz I
    Adv Exp Med Biol; 2020; 1216():65-77. PubMed ID: 31894548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk.
    Santhakumar AB; Bulmer AC; Singh I
    J Hum Nutr Diet; 2014 Feb; 27(1):1-21. PubMed ID: 24205990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older adults with frailty syndrome present an altered platelet function and an increased level of circulating oxidative stress and mitochondrial dysfunction biomarker GDF-15.
    Arauna D; García F; Rodríguez-Mañas L; Marrugat J; Sáez C; Alarcón M; Wehinger S; Espinosa-Parrilla Y; Palomo I; Fuentes E
    Free Radic Biol Med; 2020 Mar; 149():64-71. PubMed ID: 31926293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets redox balance assessment: Current evidence and methodological considerations.
    Komosa A; Rzymski P; Perek B; Ropacka-Lesiak M; Lesiak M; Siller-Matula JM; Poniedziałek B
    Vascul Pharmacol; 2017 Aug; 93-95():6-13. PubMed ID: 28684282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets.
    Saluk-Juszczak J; Olas B; Nowak P; Staroń A; Wachowicz B
    Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):422-8. PubMed ID: 17933501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and oxygen radicals: mechanisms of functional modulation.
    Pulcinelli FM; Pignatelli P; Violi F; Gazzaniga PP
    Haematologica; 2001 Nov; 86(11 Suppl 2):31-4. PubMed ID: 11926772
    [No Abstract]   [Full Text] [Related]  

  • 19. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study.
    Liu CK; Lyass A; Larson MG; Massaro JM; Wang N; D'Agostino RB; Benjamin EJ; Murabito JM
    Age (Dordr); 2016 Feb; 38(1):1. PubMed ID: 26695510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.